Latest Articles

Publication Date
Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI Proactive Investors UK

Published: Feb. 22, 2025, 5:05 a.m.
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials after key milestone Proactive Investors UK

Published: Feb. 20, 2025, 3:20 p.m.
COVID-19 and our understanding of vitamin D and immune function.

The interaction between vitamin D and the immune system is perhaps the most well recognised extraskeletal facet of vitamin D, encompassing early studies of therapy for TB and leprosy through …

Published: Feb. 20, 2025, midnight
Endometriosis imaging agent impresses at clinical trials - Health Imaging

Endometriosis imaging agent impresses at clinical trials Health Imaging

Published: Feb. 10, 2025, 12:39 p.m.
Efficacy and Safety of Chinese Patent Medicines Combined with Conventional Therapies for Endometriosis: A Systematic Review and Bayesian Network Meta-Analysis.

Conventional hormonal treatments for endometriosis (EMs) are often associated with significant side effects. In recent years, many clinical trials and studies have highlighted the remarkable efficacy of Chinese patent medicines …

Published: Feb. 8, 2025, midnight
Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA - openPR

Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA openPR

Published: Feb. 6, 2025, 7:24 p.m.
Endometriosis Pipeline 2024: Detailed Clinical Trials - openPR

Endometriosis Pipeline 2024: Detailed Clinical Trials openPR

Published: Jan. 16, 2025, 6:40 p.m.
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review.

Overweight and obesity-chronic illnesses in which an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass resulting in adverse metabolic, biomechanical, and psychosocial health consequences-negatively impact female …

Published: Jan. 6, 2025, midnight
Ananda set for heightened industry interest as clinical trials advance - broker - Proactive Investors UK

Ananda set for heightened industry interest as clinical trials advance - broker Proactive Investors UK

Published: Nov. 22, 2024, 1 p.m.
Efficacy and Safety of Oral Gonadotropin-Releasing Hormone Antagonist, Relugolix, in Endometriosis: A Meta-Analysis of Randomized Clinical Trials.

Published: Nov. 20, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!